STILPANE Tablet Ref.[50536] Active ingredients: Caffeine Codeine Meprobamate Paracetamol

Source: Health Products Regulatory Authority (ZA)  Publisher: PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191

Product name and form

STILPANE (tablets).

Pharmaceutical Form

Green, biconvex tablet, debossed “C26” on the one side and bisected on the other side.

Qualitative and quantitative composition

Each STILPANE tablet contains:

Meprobamate 150 mg
Codeine phosphate 8 mg
Paracetamol 320 mg
Caffeine anhydrous 32 mg

Preservatives: Nipastat 0,02% m/m

Sugar free.

Active Ingredient Description
Caffeine

Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.

Codeine

Codeine is a centrally acting weak analgesic. Codeine exerts its effect through μ opioid receptors, although codeine has low affinity for these receptors, and its analgesic effect is due to its conversion to morphine. Codeine, particularly in combination with other analgesics such as paracetamol, has been shown to be effective in acute nociceptive pain. The anti-tussive activity of codeine is probably due to its depressant effect on the medullary cough centre in the brain.

Meprobamate

Meprobamate is a carbamate with hypnotic, sedative and some muscle relaxant properties. It is used for the short-term treatment of anxiety states, muscle tension and associated conditions where anxiety is present. In therapeutic doses its sedative effect rather than a direct action may be responsible for muscle relaxation.

Paracetamol

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.

List of Excipients

Dye lake green (C.I No’s: 47005, 42090, 15985), magnesium stearate, nipastat, povidone K25, sodium starch glycollate, starch, talc.

Pack sizes and marketing

100 tablets are packed in aluminium/PVC blister strips. The strips are packed, together with a leaflet into a unit carton.

500 tablets are packed into a white polypropylene (PP) securitainer, together with a foam insert and a leaflet and sealed with a white polyethylene cap.

1000 tablets are packed into amber PVC jars together with a foam insert and a leaflet and sealed with a screwcap.

Not all packs and pack sizes are necessarily marketed.

Marketing authorization holder

PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191

Marketing authorization dates and numbers

M/2.9/2

Date of registration: 23 November 1979
Date of the most recent amendment to the professional information as approved by the Authority: 20 April 2012

Drugs

Drug Countries
STILPANE South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.